- Home
- Applications
- USA
- biopsy
Show results for
Refine by
Biopsy Product Applications In Usa
13 applications found
Transvaginal uterine access is a common in-office procedure performed for a variety of reasons including IUD placement, endometrial biopsy, embryo transfer, diagnostic and operative hysteroscopy. These procedures are rapidly growing as they can be relatively quick, convenient, and do not require general anesthesia or a full Operating Room setup. ...
ByCrossBay Medical based in San Diego, CALIFORNIA (USA)
SNAQ-SEQ ctDNA spike-in standards Liquid biopsies offer the promise of earlier detection and monitoring of cancer patients’ treatment progression. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)
In 2022, nearly 30,000 Alabama men and women will be diagnosed with cancer, and more than 10,000 will die from the disease. The Information is Power campaign facilitated through the HudsonAlpha Institute for Biotechnology has offered free or reduced-cost hereditary cancer risk testing to our community of Northern Alabama in collaboration with Kailos Genetics since 2015. Information is Power uses the Expedio™ Hereditary Cancer Screening Service to review 33 genes for genetic mutations that may increase your ...
ByKailos Genetics, LLC. based in Huntsville, ALABAMA (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Partial mastectomy is another name for a lumpectomy, a breast-conserving surgery that only removes the part of the breast that has cancer and a small rim around it to help prevent ...
ByDilon Technologies Inc. based in Newport News, VIRGINIA (USA)
Following extensive research and development, Biostage has evolved its technology to optimize the interaction of mesenchymal stem cells seeded on a biocompatible scaffold. Preclinical studies suggest that, once implanted, the scaffold seeded with the patient’s own cells signals the stem cell niche to guide the regeneration of a biological ...
ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc. based in Holliston, MASSACHUSETTS (USA)
Comfortable and Efficient Compression Therapy Solutions . Lymphedema is swelling caused by a build-up of lymph fluid in the body. Lymph nodes are found throughout the body. Unfortunately, the lymph nodes near the breast can sometimes be affected by breast cancer treatment and cause the patient to develop lymphedema. Breast Cancer Related Lymphedema is usually related to axillary lymph node surgery and radiation therapy, but doctors and researchers still aren’t sure why some people get lymphedema and others ...
ByAIROS Medical Inc based in Audubon, PENNSYLVANIA (USA)
High Performance Across the Breadth of Biotech. The NX One is a perfect fit for a wide variety of sectors and application areas spanning fundamental biological research to industrial and clinical workflows. Access your cells faster and at a fraction of the ...
ByNodexus Inc. based in Hayward, CALIFORNIA (USA)
Lung cancer is the leading cause of cancer deaths worldwide. More Americans die each year from lung cancer than from prostate, breast and colon cancers ...
ByAuris Health, Inc. based in Redwood City, CALIFORNIA (USA)
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)